Drugs / CTX
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 3 | NCT03006614 Comparator | Apr 2016 → Mar 2018 | breast carcinoma, chemotherapy-induced toxicity | Shi Yanxia | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CTX | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03006614 ↗ |